Once-weekly dulaglutide for the treatment of youths with type 2 diabetes
Yearbook of pediatric endocrinology(2023)
Abstract
Brief summary: This randomized, double-blind, phase 3 trial of youths with inadequately controlled T2D, dulaglutide treatment was superior to placebo in reducing the glycated hemoglobin level at 26 weeks.
MoreTranslated text
Key words
diabetes,treatment,once-weekly
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined